Robot-assisted Laparoscopic Adenomyomectomy

Robot-assisted Laparoscopic Adenomyomectomy | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Robot-assisted Laparoscopic Adenomyomectomy Taner Usta, Salih Yilmaz, Aysel Ozkaynak, Gizem Nil Ceylan, Ahmet Kale, and 1 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-2322563/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Adenomyosis is a benign uterine disorder where endometrial gland and stromal tissue are abnormally located within the myometrium. The common symptoms of adenomyosis are abnormal uterine bleeding (menorrhagia), dysmenorrhea, dyspareunia and infertility. The gold-standard method for treating adenomyosis is hysterectomy. For patients who desire to preserve their uterus, an alternative therapy would be adenomyomectomy which is sparing uterus. Such a procedure may be performed with open surgery or minimally invasive surgery. It is obvious that minimal invasive surgery would be better for the patient’s health. However, there is inadequate evidence to decidedly say which invasive surgery which invasive surgery would be best for the patient. We suggest that one of the newest techniques, robotic surgery is to be preferred an alternative approach for gynecological operations as well as would be an option for uterine surgery. This technique would allow for 3-D visualization and multijoint endowrist movement, which compared to laparoscopy, yields various advantages for surgeons. We therefore recruit seven participants diagnosed with symptomatic adenomyosis who admitted to Endometriosis and Chronic Pelvic Pain Center of Acibadem Altunizade Hospital between March 2019and January 2021 requested to preserve fertility. They all underwent robotic adenomyomectomy. The parameters evaluated herein will be, whether the pain and bleeding scores changed during the postoperative period, amount of blood loss during the operation and the associated decrease in Hg levels. Robotic adenomyomectomy is one of the uterus-sparing adenomyosis surgery methods and is safely applied in selected patients. Adenomyomectomy adenomyosis uterus-sparing surgery robotic surgery fertility Figures Figure 1 Figure 2 Figure 3 Introduction Adenomyosis is a benign uterine disorder where endometrial gland and stromal tissue are abnormally located within the myometrium. It often causes abnormal uterine bleeding, dysmenorrhea, dyspareunia and infertility[ 1 ]. There are various theories on its pathogenesis and its effect on pain, bleeding and infertility are not fully understood yet. Nonetheless, increased uterine contractility, altered endometrial receptivity, induced neoangiogenesis, impaired uterotubal transport and some inflammatory factors have been implicated in adenomyosis[ 2 ]. The pharmacologic treatment of adenomyosis is similar to endometriosis. Currently, the gold-standard treatment method of adenomyosis is hysterectomy [ 3 ]. However, a definitive treatment method has not been acceptable in patients who want to preserve their uterus or desire to have children [ 4 ]. Currently, due to the increasing age of women who bear a child, uterus-sparing surgery has gaining importance in the treatment of adenomyosis compared to hysterectomy. Many methods have been described for the reduction of adenomyotic tissue in adenomyosis surgery. These techniques are classified into two categories based on whether the type of adenomyosis is focal or diffuse. Adenomyomectomy was first accomplished as a conservative surgery by Hyams in 1952[ 5 ], at that time surgical methods were consisting of wedge resection of focal adenomyosis and suturing. Spesifically in focal adenomyosis surgery, in order to reduce the risk of recurrence and complications these techniques were further modified such as transverse H incision in 2004 by Fujishita and colleagues and wedge uterine wall excision in 2011[ 6 ], [ 7 ]. For diffuse adenomyosis surgery, Nishida suggested asymmetrical dissection of the uterus in 2010[ 8 ]. In 2011, as an great importance in history of conservative adenomyosis surgery, Osada introduces the triple flap method[ 9 ]. In this procedure, via laparotomy adenomyotic tissue is completely resected, leaving a 1 cm margin of tissue adjacent to both endometrial and serosal layers. This is followed by uterine wall reconstruction[ 10 ]. Uterus-sparing surgery can be performed as laparotomic or minimally invasive surgery (laparoscopic or robot-assisted laparoscopic). However, the lack of a clear boundary between adenomyosis tissue and normal myometrial tissue makes surgery challenging. Another difficulty is reconstruction of the uterus by suturing. Robotic surgery allows 3D visualization and multijoint endowrist movement that facilitates suturing, which has several advantages compared to laparoscopy. For this reason robot-assisted laparoscopic surgery can be more suitable for adenomyosis surgery especially if patient have been diagnosed with a concomitant Deep infiltrative endometriosis (DIE). Seven of the patients diagnosed with symptomatic adenomyosis admitted to Endometriosis and Chronic Pelvic Pain Center of Acibadem Altunizade Hospital between March 2019 and January 2021 requested to preserve fertility and were recruited for this study. They underwent robotic adenomyomectomy and analyzed retrospectively. The parameters evaluated herein will be, whether the pain and bleeding scores changed during the postoperative period and blood loss during the operation. Patients & Methods Patients Six of the patients diagnosed as focal adenomyosis and one patient with diffuse adenomyosis admitted to the Endometriosis and Chronic Pelvic Pain Center of Acibadem Altunizade Hospital between March 2019 and January 2021 who requested to preserve fertility were enrolled in the study. Informed consent was obtained from all individual participants included in the study. All patients with focal adenomyosis have already endometriosis and five of them were complicated with DIE and three of these patients also have ovarian endometriomas concomitantly. All patients were presented with dysmenorrhea and abnormal uterine bleeding. Five of six patients were presented with dyspareunia and three of them were presented with dyschezia. The demographic characteristics were in Table 1. The transvaginal ultrasonography (TvUSG) revealed DIE and focal adenomyosis on the posterior wall of the uterus at six patients and diffuse adenomyosis at one patient and no DIE findings at this patient. Adenomyotic tissue diameters were recorded with the anterior and posterior uterine wall diameters by TvUSG. All seven patients underwent robot-assisted laparoscopic surgery. The operation, incision and suturing times, incision type and blood loss were recorded. Numeric Rating Score (NRS) was recorded preoperatively and postoperatively in all patients. This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Acıbadem University. Surgical Technique: All cases were positioned in the low lithotomy position with arms closed and shoulders supported. Before starting the operation, a uterine manipulator (Clearview, Clinical Innovations, Utah, USA) was placed in all cases, except for one patient who had no previous sexual experience. For this patient, the uterus was suspended to the anterior abdominal wall with a prolene suture. For the Da Vinci-Xi robotic system (Intuitive Surgical Inc, Sunnyvale, California, USA), four 8mm trocars and one 5mm assistant trocar were placed on the abdominal wall and the robot was docked. In cases with focal adenomyosis and endometriosis, endometriosis surgery was completed first. Then, a serosal incision was made on the adenomyosis tissue with monopolar scissors parallel to the long axis of the adenomyosis tissue. By controlling the bleeding with bipolar energy, the incision was deepened with monopolar scissors, and the adenomyotic tissue was divided in two parts by entering the endometrial cavity. Then, when the incision was vertical, the right and left (upper and lower if the incision is lateral) adenomyotic tissue was excised by maintaining sufficient subserosal and subendometrial myometrial tissue. The endometrial defect was then sutured with an absorbable suture. Then, one side serosal tissue was sutured to the contralateral subendometrial myometrium layer with a barbed suture (V-loc, Covidien, Minneapolis, USA) on both sides. It was sutured with the bi-flap technique without leaving any defect. In the case with diffuse adenomyosis, an anteroposterior incision was made starting from the fundus of the uterus to the endometrial cavity and uterus was divided into two parts as right and left. Then the right and left adenomyotic tissues were excised. The endometrium was sutured with an absorbable suture and the uterus was sutured with barbed sutures using the bi-flap technique. Finally, the robot undocking was done. Results Between March 2019 and January 2021, seven patients with adenomyosis who desired to preserve their uterus were enrolled in this study. Diffuse adenomyosis was found in 1 of these 7 patients, and focal adenomyosis was found in the other 6 patients. Concurrent endometriosis was present in 6 cases with focal adenomyosis (5 of all with DIE + endometrioma and one with only endometrioma). All cases with focal adenomyosis and Diffuse Infiltrative Endometriosis had dysmenorrhea, dyspareunia (not seen in virgin patient and abnormal uterine bleeding (menorrhagia) with chronic pelvic pain. The patient with endometrioma and focal adenomyosis was presented dysmenorrhea and menorrhagia. Abnormal uterine bleeding (menorrhagia) and dysmenorrhea were the main complaints in the case with diffuse adenomyosis. Endometriosis was not detected in this patient. In all patients with focal adenomyosis, lesions were found in posterior location of uterus. Patient’s demographics are shown in table 1, all patients had dysmenorrhea and menorrhagia, dyspareunia were seen, five of them. Mean preoperative hg was 12.3 ± 0.56. Surgical outcomes of patients were shown in table 2. Mean operation time was 283.4min ± 28.6, mean incision time and mean suturing time were 52.2 ± 35.3 min and 57.7 ± 37.3 min respectively. Mean blood loss was 240mL. Mean hospital stay was 2.4 day. No intraoperative and postoperative complications were seen. All patients were followed up as symptom-free in the postoperative period. Mean preoperative VAS pain score were 7.8 ± 1.345. Mean postoperative VAS pain score in 6th month were 0.57 ± 0.5, in 1st year 0.42 ± 0.5. Therefore significant decrease in VAS score were recorded. Table:1 Patient Demographics Case Age BMI Parity Symptoms Preop VAS Score Endometriosis Location of adenomyosis Size of adenomyosis Pathology 1 36 21,3 0 Dysmenorrhea Dyspareunia Dyschezia Menorrhagia 9 OMA DIE Posterior 41*23 cm Adenomyosis 2 30 22,2 0 Dysmenorrhea Dyspareunia Dyschezia Menorrhagia 8 OMA DIE Posterior 40*23 cm Adenomyosis 3 38 23,1 0 Dysmenorrhea Menorrhagia 8 OMA Posterior 40*30 cm Adenomyosis 4 31 22,8 1 Dysmenorrhea Dyspareunia Menorrhagia 6 DIE Posterior 41*33 cm Adenomyosis 5 32 22,3 0 Dysmenorrhea Dyspareunia Menorrhagia 7 OMA DIE Posterior 50*40 cm Adenomyosis 6 37 21,4 1 Dysmenorrhea Dyspareunia Menorrhagia 7 DIE Posterior 42*34 cm Adenomyosis 7 41 22,8 0 Dysmenorrhea Menorrhagia 10 No Diffuse Diffuse Adenomyosis OMA: Ovarian endometrioma, DIE: Deep infiltrating endometriosis Table:2 Surgical Outcomes Case Operation time (min) Incision time (min) Suturing time (min) Insicion type Blood loss (ml) Hospital stay (day) Postop 6th mo VAS score Postop 1st yr VAS score 1 246 21 39 Vertical 200 3 1 1 2 300 48 38 Vertical 220 3 0 0 3 337 87 92 Vertical 100 2 1 0 4 296 34 31 Vertical 250 3 0 0 5 254 33 28 Lateral 310 2 0 0 6 281 21 41 Lateral 250 2 1 1 7 270 122 135 Vertical 350 2 1 1 Mean 283.4 (246–300) min 52.2(21–122) min 57.7 (28–135) min * 240 (200–350) 2.4 (2–3) 0.57 ± 0.5 0.42 ± 0.5 Discussion Adenomyosis is a benign disorder of uterus and remarkable cause of dysmenorrhea, dyspareunia, menorrhagia and infertility of which mechanism has not yet been fully resolved [ 2 ] . Robotic surgery is used not only in hysterectomy in gynecology, but also in various fields such as surgeries for endometriosis patients with pelvic nerves involved and pelvic organ prolapse. [ 11 ], [ 12 ] The gold standard of its treatment is hysterectomy. Nowadays, the mean age of women on giving birth to their first child is gradually rising. Therefore patients are more likely to prefer conservative surgery. A consensus has not yet been reached regarding the conservative surgical approach to be used in the treatment of women with the desire for reserving fertility. These uterus-sparing methods are aimed at significant improvement of symptoms permanently. Many techniques have been developed for the incomplete and complete excision of the tissue in adenomyosis surgery. The triple flap method described by Osada in 2011 is of great importance in the history of conservative adenomyosis surgery, which first started with wedge resection described by Hyams in 1952 and was developed furthermore later on. In Osada procedure, the abnormal adenomyotic tissue is completely resected, leaving a 1 cm margin of tissue adjacent to both endometrial and serosal layers. This is followed by uterine wall reconstruction[ 10 ]. Osada performed this surgery by laparotomy and now conservative adenomyosis surgery can be planned as both laparotomy and minimally invasive approach. Unfortunately, lack of a clear demarcation line between adenomyosis tissue and normal myometrial tissue makes this surgery arduous. Another challenging step is suturing the resulting defective tissue without leaving a gap which is an inevitable necessity for patients willing to conceive. Minimally invasive approach can be considered as an alternative to laparotomy in terms of patient comfort [ 10 ]. Recent evidences suggest that minimally invasive techniques are linked to reduced bleeding, rapid recovery, less hospital stay and less complications when compared to laparotomy [ 13 ]. As a result of studies which comparing these techniques, claimed that laparoscopy may be a choice in focal lesions due to less pain, rapid recovery and decreased blood loss, but laparotomy may be preferred in diffuse adenomyosis due to reduced menorrhagia and recurrence [ 14 ], [ 15 ]. Meanwhile robotic surgery is becoming more and more widespread in the medical field, it makes technically challenging surgeries such as adenomyomectomy easier to perform[ 16 ]. Robotic surgery, which is a minimally invasive surgical method, seems to be more capable to fully remove adenomyotic tissue as it increases the wrist movements of the surgeon. Due to the linear movements of the laparoscopic instruments, it is difficult to suture the defective area. Thanks to the 3D image quality provided by the robotic system and the multi-joint 'endowrist' movement of the robotic arms in 7 different axes, suturation can be performed without leaving any defective areas behind. In a study conducted by Chong et al in 2016 which compares the long term efficacy of robotic adenomyomectomy and laparoscopic adenomyomectomy showed no statistical difference in terms of surgical outcomes, except the prolonged duration of the operation time and suturing time which is regarded as a disadvantage of robotic surgery[ 17 ]. A case series were done in 2016 by Chung with 4 patients whom underwent robot-assisted laparoscopic adenomyomectomy. They found that robot assisted laparoscopy was superior compared to open myomectomy concerning blood loss, hospital stays, recovery times and adhesion rates. In 2019, Shim et al compared surgical outcomes between robotic and laparoscopic adenomyomectomy. Laparoscopy demonstrated no statistical difference found weight of adenomyotic tissue removed and duration of hospital stay[ 18 ]. According to literature review, robotic adenomyomectomy studies performed so far are demonstrated in Table 3 . Table 3 Robotic adenomyomectomy surgeries in the literature Year Author Design N Type Technique Results 2013 Barton et al[ 19 ] Retrospective Cohort 2 Focal Robot-assisted adenomyomectomy Mean op time:169.5 ± 47.3 min Mean Blood Loss:25mL 2015 Ma et al[ 20 ] Retrospective Cohort 23 Focal Robot-assisted Laparoscopy As compared with L/T and Robotic surgery , Robotic Surgery had Less estimated blood loss during operation(250 ± 249.6 mL vs 690.91 ± 776.47 mL) Shorter postoperative hospital days (2.57 vs 4.0 days). The dysmenorrhea and pelvic pain of the patients nearly disapeared after surgery. 2016 Chong et al[ 21 ] Prospective Cohort 33 Focal:27 Diffuse:6 Robotic:8 L/S:25 No difference in blood loss, Hg change, length of hospital stay, complication rate Mean op time& suturing time, longer in robotic group 2016 Chung et al[ 22 ] Case Series 4 Focal:4 Robot-Assisted Laparoscopic Surgery Mean op time: 159.25 ± 93.06 Mean estimated blood loss: 117.5 ± 56.78 mL Dysmenorrhea&Pelvic Pain nearly disappeard 1–2 weeks after surgery 2019 Shim et al[ 23 ] Retrospective Cohort 43 Focal:35 Diffuse:8 L/S:21(Focal:17 Diffuse:4) Robotic:22(Focal:18 Diffuse:4) No difference in operative time, estimated blood loss, weight of resected nodule, length of hospital stay No serious perioperative complication observed in both group 2021 Hijazi et al[ 24 ] Retrospective Cohort 34 Focal:14 Diffuse:19 Robot-assisted Laparoscopy Mean uterine wall thickness 4.02 cm ± 1.11 dropping to 2.37 cm ± 0.84 postoperatively this led to a mean drop of 41% in the thickness of the affected Wall Total operative time, min, mean ± SD 279.82 ± 69.02 (141–436) EBL (mL), 296.47 ± 160.77 (50–700) Mean preoperative pain score 8.68 ± 1.12, while the postoperative mean was 0.06 ± 0.34 Hb drop, 2.31 ± 1.18 (4.7- þ0.6) Although there are not enough meta-analysis studies, according to the meta-analysis results of Lavazzo and his collagues provided a comprehensive meta-analysis of minimally invasive techniques in myoma surgery in 2016, they concluded that robotic surgery was better than laparoscopic surgery as shown in its less bleeding and blood transfusion need, lower complication rates, and shorter hospital stay in the postoperative period[ 25 ]. On the basis of these findings that robotic surgery may be superior to laparoscopy and will be preferred by surgeons and patients in conservative adenomyosis surgery. Limitations of this study are the presence of concurrent endometriosis and the fact that endometriosis surgery would be performed at the same time in most of the cases may have an impact on the decision to perform the operation with robotic approach and this can effect pain scores of the patients. Conclusion Overall these results indicate that for patients who desire to preserve their uterus, treatment is the complete removal of the adenomyotic tissue and reducing symptoms but surgical outcomes are not decisive. For the patient's comfort, minimal invasive surgery may be preferred. These results highlights the hypothesis, which was that one of the minimally invasive techniques, robotic surgery, can be used in the treatment of adenomyosis, and this may be preferred by surgeons since robotic surgery allows for greater visualization and range of movement when compared to laparoscopy. The superiority of laparoscopy to robotic surgery in perioperative result has not yet been shown clearly in studies. For this reason there has not yet been any proven technique for uterus sparing surgery in the treatment of adenomyosis. Future investigations are necessary to validate the kinds of conclusions that can be drawn from this study. Since the complete removal of adenomyotic tissue is only possible with hysterectomy, we do not have enough information about how much adenomyotic tissue remains in the uterine-sparing surgery group and how much recurrence will occur in the future. Statements And Declarations The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose. Acknowledgments All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [Taner Usta], [Salih Yilmaz]. The first draft of the manuscript was written by [Gizem Nil Ceylan] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. References J. Donnez, O. Donnez, ve M.-M. Dolmans, “Introduction”, Fertil. Steril. , c. 109, sy 3, ss. 369-370, Mar. 2018, doi: 10.1016/j.fertnstert.2018.01.035. J. Zhai, S. Vannuccini, F. Petraglia, ve L. C. Giudice, “Adenomyosis: Mechanisms and Pathogenesis”, Semin. Reprod. Med. , c. 38, sy 02/03, ss. 129-143, May. 2020, doi: 10.1055/s-0040-1716687. C. Farquhar ve I. Brosens, “Medical and surgical management of adenomyosis”, Best Pract. Res. Clin. Obstet. Gynaecol. , c. 20, sy 4, ss. 603-616, Ağu. 2006, doi: 10.1016/j.bpobgyn.2006.01.012. S. Vannuccini ve F. Petraglia, “Recent advances in understanding and managing adenomyosis”, F1000Research , c. 8, s. F1000 Faculty Rev-283, 2019, doi: 10.12688/f1000research.17242.1. L. L. Hyams, “Adenomyosis; its conservative surgical treatment (hysteroplasty) in young women”, N. Y. State J. Med. , c. 52, sy 22, ss. 2778-2784, Kas. 1952. A. Sun, M. Luo, W. Wang, R. Chen, ve J. Lang, “Characteristics and efficacy of modified adenomyomectomy in the treatment of uterine adenomyoma”, Chin. Med. J. (Engl.) , c. 124, sy 9, ss. 1322-1326, May. 2011. A. Fujishita, H. Masuzaki, K. N. Khan, M. Kitajima, ve T. Ishimaru, “Modified Reduction Surgery for Adenomyosis”, Gynecol. Obstet. Invest. , c. 57, sy 3, ss. 132-138, 2004, doi: 10.1159/000075830. M. Nishida, K. Takano, Y. Arai, H. Ozone, ve R. Ichikawa, “Conservative surgical management for diffuse uterine adenomyosis”, Fertil. Steril. , c. 94, sy 2, ss. 715-719, Tem. 2010, doi: 10.1016/j.fertnstert.2009.03.046. H. Osada, S. Silber, T. Kakinuma, M. Nagaishi, K. Kato, ve O. Kato, “Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis”, Reprod. Biomed. Online , c. 22, sy 1, ss. 94-99, Oca. 2011, doi: 10.1016/j.rbmo.2010.09.014. G. F. Grimbizis, T. Mikos, ve B. Tarlatzis, “Uterus-sparing operative treatment for adenomyosis”, Fertil. Steril. , c. 101, sy 2, ss. 472-487.e8, Şub. 2014, doi: 10.1016/j.fertnstert.2013.10.025. C. Benlice vd. , “Robotic Surgery for Deep Pelvic Endometriosis With Multidisciplinary Approach: Shaving, Wedge Resection, and Segmental Resection”, Dis. Colon Rectum , c. 65, sy 8, ss. e816-e816, Ağu. 2022, doi: 10.1097/DCR.0000000000002353. T. Usta, T. Karacan, A. Kale, S. Mutlu, ve T. Tıryakı, “Robot-assisted laparoscopic pectouteropexy: an alternative uterus-sparing technique for pelvic organ prolapse surgery”, Int. Urogynecology J. , c. 28, sy 11, ss. 1751-1753, Kas. 2017, doi: 10.1007/s00192-017-3326-3. C. Jin vd. , “Laparoscopic versus open myomectomy--a meta-analysis of randomized controlled trials”, Eur. J. Obstet. Gynecol. Reprod. Biol. , c. 145, sy 1, ss. 14-21, Tem. 2009, doi: 10.1016/j.ejogrb.2009.03.009. J. Y. Kwack, K. S. Im, ve Y.-S. Kwon, “Conservative surgery of uterine adenomyosis via laparoscopic versus laparotomic approach in a single institution: Approaching method for adenomyomectomy”, J. Obstet. Gynaecol. Res. , c. 44, sy 7, ss. 1268-1273, Tem. 2018, doi: 10.1111/jog.13658. L. Zhu, S. Chen, X. Che, P. Xu, X. Huang, ve X. Zhang, “Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution”, J. Pain Res. , c. Volume 12, ss. 1917-1924, Haz. 2019, doi: 10.2147/JPR.S205561. G. Gitas, L. Hanker, A. Rody, J. Ackermann, ve I. Alkatout, “Robotic surgery in gynecology: is the future already here?”, Minim. Invasive Ther. Allied Technol. , ss. 1-10, Oca. 2022, doi: 10.1080/13645706.2021.2010763. G. O. Chong, Y. H. Lee, D. G. Hong, Y. L. Cho, ve Y. S. Lee, “Long-Term Efficacy of Laparoscopic or Robotic Adenomyomectomy with or without Medical Treatment for Severely Symptomatic Adenomyosis”, Gynecol. Obstet. Invest. , c. 81, sy 4, ss. 346-352, 2016, doi: 10.1159/000441783. Y. J. Chung, S. Y. Kang, M. R. Choi, H. H. Cho, J. H. Kim, ve M. R. Kim, “Robot-Assisted Laparoscopic Adenomyomectomy for Patients Who Want to Preserve Fertility”, Yonsei Med. J. , c. 57, sy 6, ss. 1531-1534, Kas. 2016, doi: 10.3349/ymj.2016.57.6.1531. S. E. Barton ve A. R. Gargiulo, “Robot-assisted laparoscopic myomectomy and adenomyomectomy with a flexible CO2 laser device”, J. Robot. Surg. , c. 7, sy 2, ss. 157-162, Haz. 2013, doi: 10.1007/s11701-012-0360-5. J. Ma vd. , “Robot-Assisted Laparoscopic Adenomyomectomy: Successful Treatment of Adenomyosis Patients Who Wish Uterus-Sparing Treatment”, J. Minim. Invasive Gynecol. , c. 22, sy 6, s. S70, Kas. 2015, doi: 10.1016/j.jmig.2015.08.188. G. O. Chong, Y. H. Lee, D. G. Hong, Y. L. Cho, ve Y. S. Lee, “Long-Term Efficacy of Laparoscopic or Robotic Adenomyomectomy with or without Medical Treatment for Severely Symptomatic Adenomyosis”, Gynecol. Obstet. Invest. , c. 81, sy 4, ss. 346-352, 2016, doi: 10.1159/000441783. Y.-J. Chung, S.-Y. Kang, M.-R. Choi, H.-H. Cho, J.-H. Kim, ve M.-R. Kim, “Robot-Assisted Laparoscopic Adenomyomectomy for Patients Who Want to Preserve Fertility”, Yonsei Med. J. , c. 57, sy 6, s. 1531, 2016, doi: 10.3349/ymj.2016.57.6.1531. J. I. Shim vd. , “A comparison of surgical outcomes between robot and laparoscopy-assisted adenomyomectomy”, Medicine (Baltimore) , c. 98, sy 18, s. e15466, May. 2019, doi: 10.1097/MD.0000000000015466. A. Hijazi vd. , “Efficient myometrial defect closure in a layer by layer fashion after robot-assisted laparoscopic adenomyomectomy: a novel technique”, Obstet. Gynecol. Sci. , c. 64, sy 3, ss. 332-335, May. 2021, doi: 10.5468/ogs.21025. C. Iavazzo, I. Mamais, ve I. D. Gkegkes, “Robotic assisted vs laparoscopic and/or open myomectomy: systematic review and meta-analysis of the clinical evidence”, Arch. Gynecol. Obstet. , c. 294, sy 1, ss. 5-17, Tem. 2016, doi: 10.1007/s00404-016-4061-6. Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-2322563","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":156038925,"identity":"00db6ee1-d792-4c3c-a716-aa6cbb4c9ea7","order_by":0,"name":"Taner Usta","email":"","orcid":"","institution":"Acibadem Mehmet Ali Aydinlar University","correspondingAuthor":false,"prefix":"","firstName":"Taner","middleName":"","lastName":"Usta","suffix":""},{"id":156038927,"identity":"d2b88b08-2f27-4a38-b599-2fef15ea9d87","order_by":1,"name":"Salih Yilmaz","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA2ElEQVRIiWNgGAWjYDCCAwyMhxkYLBgY2BsYmInVwgDUIsHAwHOAZC0SCURq4bt9/MHhwjaJaPmZbww/F1TYMPC3dyfg1SJ5Lsfg8Mw2idzG2TnG0jPOpDFInDm7Aa8WgzM8DId5gVqapXMMpHnbDjMYSOQS0sL+AKylTfKM8W8itTAYgLX0SPCYEWeL5Bkeg8M85yRyZ/CklVnznEnjIegXvjPsDx/zlNnkzm8/vPk2T4WNHH97L34tYMDIBiI5DEAkD2HlYPAHRLA/IFL1KBgFo2AUjDQAAD0xRnOtZiLmAAAAAElFTkSuQmCC","orcid":"","institution":"Acibadem Altunizade Hospital","correspondingAuthor":true,"prefix":"","firstName":"Salih","middleName":"","lastName":"Yilmaz","suffix":""},{"id":156038929,"identity":"4e27eebd-1b1d-4b91-a05e-00ab39bab0c1","order_by":2,"name":"Aysel Ozkaynak","email":"","orcid":"","institution":"Acibadem Altunizade Hospital","correspondingAuthor":false,"prefix":"","firstName":"Aysel","middleName":"","lastName":"Ozkaynak","suffix":""},{"id":156038931,"identity":"45ff19b2-0d3f-4066-a242-5b28b7fd3528","order_by":3,"name":"Gizem Nil Ceylan","email":"","orcid":"","institution":"Istanbul Medeniyet University","correspondingAuthor":false,"prefix":"","firstName":"Gizem","middleName":"Nil","lastName":"Ceylan","suffix":""},{"id":156038933,"identity":"1b9e07ea-36c7-4d4a-8202-23c7b8806e33","order_by":4,"name":"Ahmet Kale","email":"","orcid":"","institution":"Health Sciences University, Kartal Lutfu Kirdar Training and Research Hospital","correspondingAuthor":false,"prefix":"","firstName":"Ahmet","middleName":"","lastName":"Kale","suffix":""},{"id":156038936,"identity":"604da2e8-7d32-4eb7-8422-7e5749eb06c9","order_by":5,"name":"Engin Oral","email":"","orcid":"","institution":"Bezmialem Vakif University","correspondingAuthor":false,"prefix":"","firstName":"Engin","middleName":"","lastName":"Oral","suffix":""}],"badges":[],"createdAt":"2022-11-28 20:59:17","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-2322563/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-2322563/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":29781447,"identity":"96f40a8d-459f-4733-8df1-3f742d138bd6","added_by":"auto","created_at":"2022-12-01 16:20:05","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":969848,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cem\u003eVertical insicion on the adenomyosis tissue\u003c/em\u003e\u003c/p\u003e","description":"","filename":"floatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-2322563/v1/a0c7de95dd2b3baf3c6658d4.png"},{"id":29781446,"identity":"ddbe2b8e-0a10-4208-ab64-351f59ade1b2","added_by":"auto","created_at":"2022-12-01 16:20:05","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":873284,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cem\u003eExcision of the adenomyosis tissue\u003c/em\u003e\u003c/p\u003e","description":"","filename":"floatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-2322563/v1/d4a2ca82686b21c7381db1c1.png"},{"id":29782410,"identity":"6cf847d5-6da8-4a6e-973d-e33bfbaa7163","added_by":"auto","created_at":"2022-12-01 16:28:06","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":950057,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cem\u003eSuturing of the residual tissue after excision of the adenomyosis tissue\u003c/em\u003e\u003c/p\u003e","description":"","filename":"floatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-2322563/v1/fa7a79c8204b87ed09290aab.png"},{"id":29876431,"identity":"69df7b06-c760-4c23-8ffd-84c1347652a7","added_by":"auto","created_at":"2022-12-04 22:59:24","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3646658,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-2322563/v1/02b855f8-08d8-4656-8caa-1143e2b50819.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Robot-assisted Laparoscopic Adenomyomectomy","fulltext":[{"header":"Introduction","content":"\u003cp\u003eAdenomyosis is a benign uterine disorder where endometrial gland and stromal tissue are abnormally located within the myometrium. It often causes abnormal uterine bleeding, dysmenorrhea, dyspareunia and infertility[\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. There are various theories on its pathogenesis and its effect on pain, bleeding and infertility are not fully understood yet. Nonetheless, increased uterine contractility, altered endometrial receptivity, induced neoangiogenesis, impaired uterotubal transport and some inflammatory factors have been implicated in adenomyosis[\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e]. The pharmacologic treatment of adenomyosis is similar to endometriosis. Currently, the gold-standard treatment method of adenomyosis is hysterectomy [\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eHowever, a definitive treatment method has not been acceptable in patients who want to preserve their uterus or desire to have children [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e]. Currently, due to the increasing age of women who bear a child, uterus-sparing surgery has gaining importance in the treatment of adenomyosis compared to hysterectomy. Many methods have been described for the reduction of adenomyotic tissue in adenomyosis surgery. These techniques are classified into two categories based on whether the type of adenomyosis is focal or diffuse. Adenomyomectomy was first accomplished as a conservative surgery by Hyams in 1952[\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e], at that time surgical methods were consisting of wedge resection of focal adenomyosis and suturing. Spesifically in focal adenomyosis surgery, in order to reduce the risk of recurrence and complications these techniques were further modified such as transverse H incision in 2004 by Fujishita and colleagues and wedge uterine wall excision in 2011[\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e], [\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e]. For diffuse adenomyosis surgery, Nishida suggested asymmetrical dissection of the uterus in 2010[\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. In 2011, as an great importance in history of conservative adenomyosis surgery, Osada introduces the triple flap method[\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eIn this procedure, via laparotomy adenomyotic tissue is completely resected, leaving a 1 cm margin of tissue adjacent to both endometrial and serosal layers. This is followed by uterine wall reconstruction[\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eUterus-sparing surgery can be performed as laparotomic or minimally invasive surgery (laparoscopic or robot-assisted laparoscopic). However, the lack of a clear boundary between adenomyosis tissue and normal myometrial tissue makes surgery challenging. Another difficulty is reconstruction of the uterus by suturing. Robotic surgery allows 3D visualization and multijoint endowrist movement that facilitates suturing, which has several advantages compared to laparoscopy. For this reason robot-assisted laparoscopic surgery can be more suitable for adenomyosis surgery especially if patient have been diagnosed with a concomitant Deep infiltrative endometriosis (DIE).\u003c/p\u003e \u003cp\u003eSeven of the patients diagnosed with symptomatic adenomyosis admitted to Endometriosis and Chronic Pelvic Pain Center of Acibadem Altunizade Hospital between March 2019 and January 2021 requested to preserve fertility and were recruited for this study. They underwent robotic adenomyomectomy and analyzed retrospectively. The parameters evaluated herein will be, whether the pain and bleeding scores changed during the postoperative period and blood loss during the operation.\u003c/p\u003e"},{"header":"Patients \u0026 Methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003ePatients\u003c/h2\u003e \u003cp\u003eSix of the patients diagnosed as focal adenomyosis and one patient with diffuse adenomyosis admitted to the Endometriosis and Chronic Pelvic Pain Center of Acibadem Altunizade Hospital between March 2019 and January 2021 who requested to preserve fertility were enrolled in the study. Informed consent was obtained from all individual participants included in the study.\u003c/p\u003e \u003cp\u003eAll patients with focal adenomyosis have already endometriosis and five of them were complicated with DIE and three of these patients also have ovarian endometriomas concomitantly. All patients were presented with dysmenorrhea and abnormal uterine bleeding. Five of six patients were presented with dyspareunia and three of them were presented with dyschezia. The demographic characteristics were in Table\u0026nbsp;1. The transvaginal ultrasonography (TvUSG) revealed DIE and focal adenomyosis on the posterior wall of the uterus at six patients and diffuse adenomyosis at one patient and no DIE findings at this patient. Adenomyotic tissue diameters were recorded with the anterior and posterior uterine wall diameters by TvUSG. All seven patients underwent robot-assisted laparoscopic surgery. The operation, incision and suturing times, incision type and blood loss were recorded. Numeric Rating Score (NRS) was recorded preoperatively and postoperatively in all patients.\u003c/p\u003e \u003cp\u003e This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Acıbadem University.\u003c/p\u003e \u003c/div\u003e\n\u003ch3\u003eSurgical Technique:\u003c/h3\u003e\n\u003cp\u003eAll cases were positioned in the low lithotomy position with arms closed and shoulders supported. Before starting the operation, a uterine manipulator (Clearview, Clinical Innovations, Utah, USA) was placed in all cases, except for one patient who had no previous sexual experience. For this patient, the uterus was suspended to the anterior abdominal wall with a prolene suture. For the Da Vinci-Xi robotic system (Intuitive Surgical Inc, Sunnyvale, California, USA), four 8mm trocars and one 5mm assistant trocar were placed on the abdominal wall and the robot was docked. In cases with focal adenomyosis and endometriosis, endometriosis surgery was completed first. Then, a serosal incision was made on the adenomyosis tissue with monopolar scissors parallel to the long axis of the adenomyosis tissue. By controlling the bleeding with bipolar energy, the incision was deepened with monopolar scissors, and the adenomyotic tissue was divided in two parts by entering the endometrial cavity. Then, when the incision was vertical, the right and left (upper and lower if the incision is lateral) adenomyotic tissue was excised by maintaining sufficient subserosal and subendometrial myometrial tissue. The endometrial defect was then sutured with an absorbable suture. Then, one side serosal tissue was sutured to the contralateral subendometrial myometrium layer with a barbed suture (V-loc, Covidien, Minneapolis, USA) on both sides. It was sutured with the bi-flap technique without leaving any defect.\u003c/p\u003e \u003cp\u003eIn the case with diffuse adenomyosis, an anteroposterior incision was made starting from the fundus of the uterus to the endometrial cavity and uterus was divided into two parts as right and left. Then the right and left adenomyotic tissues were excised. The endometrium was sutured with an absorbable suture and the uterus was sutured with barbed sutures using the bi-flap technique. Finally, the robot undocking was done.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003e \u003c/p\u003e"},{"header":"Results","content":"\u003cp\u003eBetween March 2019 and January 2021, seven patients with adenomyosis who desired to preserve their uterus were enrolled in this study.\u003c/p\u003e \u003cp\u003eDiffuse adenomyosis was found in 1 of these 7 patients, and focal adenomyosis was found in the other 6 patients. Concurrent endometriosis was present in 6 cases with focal adenomyosis (5 of all with DIE\u0026thinsp;+\u0026thinsp;endometrioma and one with only endometrioma). All cases with focal adenomyosis and Diffuse Infiltrative Endometriosis had dysmenorrhea, dyspareunia (not seen in virgin patient and abnormal uterine bleeding (menorrhagia) with chronic pelvic pain. The patient with endometrioma and focal adenomyosis was presented dysmenorrhea and menorrhagia. Abnormal uterine bleeding (menorrhagia) and dysmenorrhea were the main complaints in the case with diffuse adenomyosis. Endometriosis was not detected in this patient. In all patients with focal adenomyosis, lesions were found in posterior location of uterus. Patient\u0026rsquo;s demographics are shown in table 1, all patients had dysmenorrhea and menorrhagia, dyspareunia were seen, five of them. Mean preoperative hg was 12.3\u0026thinsp;\u0026plusmn;\u0026thinsp;0.56. Surgical outcomes of patients were shown in table 2. Mean operation time was 283.4min\u0026thinsp;\u0026plusmn;\u0026thinsp;28.6, mean incision time and mean suturing time were 52.2\u0026thinsp;\u0026plusmn;\u0026thinsp;35.3 min and 57.7\u0026thinsp;\u0026plusmn;\u0026thinsp;37.3 min respectively. Mean blood loss was 240mL. Mean hospital stay was 2.4 day.\u003c/p\u003e \u003cp\u003eNo intraoperative and postoperative complications were seen. All patients were followed up as symptom-free in the postoperative period. Mean preoperative VAS pain score were 7.8\u0026thinsp;\u0026plusmn;\u0026thinsp;1.345. Mean postoperative VAS pain score in 6th month were 0.57\u0026thinsp;\u0026plusmn;\u0026thinsp;0.5, in 1st year 0.42\u0026thinsp;\u0026plusmn;\u0026thinsp;0.5. Therefore significant decrease in VAS score were recorded.\u003c/p\u003e \u003cp\u003e \u003cem\u003eTable:1 Patient Demographics\u003c/em\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"No\" id=\"Taba\" border=\"1\"\u003e \u003ccolgroup cols=\"10\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c10\" colnum=\"10\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCase\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eAge\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eBMI\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eParity\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eSymptoms\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003ePreop VAS Score\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eEndometriosis\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c8\"\u003e \u003cp\u003eLocation of adenomyosis\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c9\"\u003e \u003cp\u003eSize of adenomyosis\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c10\"\u003e \u003cp\u003ePathology\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e36\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e21,3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eDysmenorrhea\u003c/p\u003e \u003cp\u003eDyspareunia\u003c/p\u003e \u003cp\u003eDyschezia\u003c/p\u003e \u003cp\u003eMenorrhagia\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e9\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003eOMA\u003c/p\u003e \u003cp\u003eDIE\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003ePosterior\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e41*23 cm\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c10\"\u003e \u003cp\u003eAdenomyosis\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e30\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e22,2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eDysmenorrhea\u003c/p\u003e \u003cp\u003eDyspareunia\u003c/p\u003e \u003cp\u003eDyschezia\u003c/p\u003e \u003cp\u003eMenorrhagia\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003eOMA\u003c/p\u003e \u003cp\u003eDIE\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003ePosterior\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e40*23 cm\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c10\"\u003e \u003cp\u003eAdenomyosis\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e38\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e23,1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eDysmenorrhea\u003c/p\u003e \u003cp\u003eMenorrhagia\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003eOMA\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003ePosterior\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e40*30 cm\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c10\"\u003e \u003cp\u003eAdenomyosis\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e31\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e22,8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eDysmenorrhea\u003c/p\u003e \u003cp\u003eDyspareunia\u003c/p\u003e \u003cp\u003eMenorrhagia\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e6\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003eDIE\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003ePosterior\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e41*33 cm\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c10\"\u003e \u003cp\u003eAdenomyosis\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e32\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e22,3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eDysmenorrhea\u003c/p\u003e \u003cp\u003eDyspareunia\u003c/p\u003e \u003cp\u003eMenorrhagia\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e7\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003eOMA\u003c/p\u003e \u003cp\u003eDIE\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003ePosterior\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e50*40 cm\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c10\"\u003e \u003cp\u003eAdenomyosis\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e6\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e37\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e21,4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eDysmenorrhea\u003c/p\u003e \u003cp\u003eDyspareunia\u003c/p\u003e \u003cp\u003eMenorrhagia\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e7\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003eDIE\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003ePosterior\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e42*34 cm\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c10\"\u003e \u003cp\u003eAdenomyosis\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e7\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e41\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e22,8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eDysmenorrhea\u003c/p\u003e \u003cp\u003eMenorrhagia\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e10\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003eNo\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003eDiffuse\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003eDiffuse\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c10\"\u003e \u003cp\u003eAdenomyosis\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eOMA: Ovarian endometrioma, DIE: Deep infiltrating endometriosis\u003c/p\u003e \u003cp\u003e \u003cem\u003eTable:2 Surgical Outcomes\u003c/em\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"No\" id=\"Tabb\" border=\"1\"\u003e \u003ccolgroup cols=\"9\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCase\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eOperation time (min)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eIncision time (min)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eSuturing time (min)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eInsicion type\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eBlood loss (ml)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eHospital stay (day)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c8\"\u003e \u003cp\u003ePostop 6th mo\u003c/p\u003e \u003cp\u003eVAS score\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c9\"\u003e \u003cp\u003ePostop 1st yr\u003c/p\u003e \u003cp\u003eVAS score\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e246\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e21\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e39\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eVertical\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e200\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e300\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e48\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e38\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eVertical\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e220\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e337\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e87\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e92\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eVertical\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e100\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e296\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e34\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e31\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eVertical\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e250\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e254\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e33\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e28\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eLateral\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e310\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e6\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e281\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e21\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e41\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eLateral\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e250\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e7\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e270\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e122\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e135\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eVertical\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e350\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMean\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e283.4 (246\u0026ndash;300) min\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e52.2(21\u0026ndash;122) min\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e57.7 (28\u0026ndash;135) min\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e*\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e240 (200\u0026ndash;350)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e2.4 (2\u0026ndash;3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e0.57\u0026thinsp;\u0026plusmn;\u0026thinsp;0.5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e0.42\u0026thinsp;\u0026plusmn;\u0026thinsp;0.5\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eAdenomyosis is a benign disorder of uterus and remarkable cause of dysmenorrhea, dyspareunia, menorrhagia\u003c/p\u003e \u003cp\u003eand infertility of which mechanism has not yet been fully resolved [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e] .\u003c/p\u003e \u003cp\u003eRobotic surgery is used not only in hysterectomy in gynecology, but also in various fields such as surgeries for endometriosis patients with pelvic nerves involved and pelvic organ prolapse. [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e], [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e]\u003c/p\u003e \u003cp\u003eThe gold standard of its treatment is hysterectomy. Nowadays, the mean age of women on giving birth to their first child is gradually rising. Therefore patients are more likely to prefer conservative surgery.\u003c/p\u003e \u003cp\u003eA consensus has not yet been reached regarding the conservative surgical approach to be used in the treatment of women with the desire for reserving fertility. These uterus-sparing methods are aimed at significant improvement of symptoms permanently. Many techniques have been developed for the incomplete and complete excision of the tissue in adenomyosis surgery. The triple flap method described by Osada in 2011 is of great importance in the history of conservative adenomyosis surgery, which first started with wedge resection described by Hyams in 1952 and was developed furthermore later on. In Osada procedure, the abnormal adenomyotic tissue is completely resected, leaving a 1 cm margin of tissue adjacent to both endometrial and serosal layers. This is followed by uterine wall reconstruction[\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. Osada performed this surgery by laparotomy and now conservative adenomyosis surgery can be planned as both laparotomy and minimally invasive approach.\u003c/p\u003e \u003cp\u003eUnfortunately, lack of a clear demarcation line between adenomyosis tissue and normal myometrial tissue makes this surgery arduous. Another challenging step is suturing the resulting defective tissue without leaving a gap which is an inevitable necessity for patients willing to conceive.\u003c/p\u003e \u003cp\u003eMinimally invasive approach can be considered as an alternative to laparotomy in terms of patient comfort [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eRecent evidences suggest that minimally invasive techniques are linked to reduced bleeding, rapid recovery, less hospital stay and less complications when compared to laparotomy [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. As a result of studies which comparing these techniques, claimed that laparoscopy may be a choice in focal lesions due to less pain, rapid recovery and decreased blood loss, but laparotomy may be preferred in diffuse adenomyosis due to reduced menorrhagia and recurrence [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e], [\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eMeanwhile robotic surgery is becoming more and more widespread in the medical field, it makes technically challenging surgeries such as adenomyomectomy easier to perform[\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eRobotic surgery, which is a minimally invasive surgical method, seems to be more capable to fully remove adenomyotic tissue as it increases the wrist movements of the surgeon. Due to the linear movements of the laparoscopic instruments, it is difficult to suture the defective area. Thanks to the 3D image quality provided by the robotic system and the multi-joint 'endowrist' movement of the robotic arms in 7 different axes, suturation can be performed without leaving any defective areas behind.\u003c/p\u003e \u003cp\u003eIn a study conducted by Chong et al in 2016 which compares the long term efficacy of robotic adenomyomectomy and laparoscopic adenomyomectomy showed no statistical difference in terms of surgical outcomes, except the prolonged duration of the operation time and suturing time which is regarded as a disadvantage of robotic surgery[\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eA case series were done in 2016 by Chung with 4 patients whom underwent robot-assisted laparoscopic adenomyomectomy. They found that robot assisted laparoscopy was superior compared to open myomectomy concerning blood loss, hospital stays, recovery times and adhesion rates.\u003c/p\u003e \u003cp\u003eIn 2019, Shim et al compared surgical outcomes between robotic and laparoscopic adenomyomectomy. Laparoscopy demonstrated no statistical difference found weight of adenomyotic tissue removed and duration of hospital stay[\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eAccording to literature review, robotic adenomyomectomy studies performed so far are demonstrated in Table \u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e3\u003c/span\u003e.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eRobotic adenomyomectomy surgeries in the literature\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eYear\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eAuthor\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eDesign\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eN\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eType\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eTechnique\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eResults\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e2013\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eBarton et al[\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e]\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eRetrospective\u003c/p\u003e \u003cp\u003eCohort\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eFocal\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eRobot-assisted adenomyomectomy\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e\u003cb\u003eMean op time:169.5\u0026thinsp;\u0026plusmn;\u0026thinsp;47.3 min\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eMean Blood Loss:25mL\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e2015\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eMa et al[\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e]\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eRetrospective\u003c/p\u003e \u003cp\u003eCohort\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e23\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eFocal\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eRobot-assisted Laparoscopy\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e\u003cb\u003eAs compared with L/T and Robotic surgery\u003c/b\u003e,\u003c/p\u003e \u003cp\u003e\u003cb\u003eRobotic Surgery had\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eLess estimated blood loss during operation(250\u0026thinsp;\u0026plusmn;\u0026thinsp;249.6 mL vs 690.91\u0026thinsp;\u0026plusmn;\u0026thinsp;776.47 mL)\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eShorter postoperative hospital days (2.57 vs 4.0 days).\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eThe dysmenorrhea and pelvic pain of the patients nearly disapeared after surgery.\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e2016\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eChong et al[\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eProspective\u003c/p\u003e \u003cp\u003eCohort\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e33\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eFocal:27\u003c/p\u003e \u003cp\u003eDiffuse:6\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eRobotic:8\u003c/p\u003e \u003cp\u003eL/S:25\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e\u003cb\u003eNo difference in blood loss, Hg change, length of hospital stay, complication rate\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eMean op time\u0026amp; suturing time, longer in robotic group\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e2016\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eChung et al[\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eCase Series\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eFocal:4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eRobot-Assisted Laparoscopic Surgery\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e\u003cb\u003eMean op time: 159.25\u0026thinsp;\u0026plusmn;\u0026thinsp;93.06\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eMean estimated blood loss: 117.5\u0026thinsp;\u0026plusmn;\u0026thinsp;56.78 mL\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eDysmenorrhea\u0026amp;Pelvic Pain nearly disappeard 1\u0026ndash;2 weeks after surgery\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e2019\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eShim et al[\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e]\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eRetrospective Cohort\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e43\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eFocal:35\u003c/p\u003e \u003cp\u003eDiffuse:8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eL/S:21(Focal:17 Diffuse:4)\u003c/p\u003e \u003cp\u003eRobotic:22(Focal:18 Diffuse:4)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e\u003cb\u003eNo difference in operative time, estimated blood loss, weight of resected nodule, length of hospital stay\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eNo serious perioperative complication observed in both group\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e2021\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eHijazi et al[\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e]\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eRetrospective Cohort\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e34\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eFocal:14\u003c/p\u003e \u003cp\u003eDiffuse:19\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003eRobot-assisted Laparoscopy\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e\u003cb\u003eMean uterine wall thickness 4.02 cm\u0026thinsp;\u0026plusmn;\u0026thinsp;1.11 dropping to 2.37 cm\u0026thinsp;\u0026plusmn;\u0026thinsp;0.84 postoperatively this led to a mean drop of 41% in the thickness of the affected Wall\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eTotal operative time, min, mean\u0026thinsp;\u0026plusmn;\u0026thinsp;SD 279.82\u0026thinsp;\u0026plusmn;\u0026thinsp;69.02 (141\u0026ndash;436)\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eEBL (mL), 296.47\u0026thinsp;\u0026plusmn;\u0026thinsp;160.77 (50\u0026ndash;700)\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eMean preoperative pain score 8.68\u0026thinsp;\u0026plusmn;\u0026thinsp;1.12, while the postoperative mean was 0.06\u0026thinsp;\u0026plusmn;\u0026thinsp;0.34\u003c/b\u003e\u003c/p\u003e \u003cp\u003e\u003cb\u003eHb drop, 2.31\u0026thinsp;\u0026plusmn;\u0026thinsp;1.18 (4.7- \u0026thorn;0.6)\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eAlthough there are not enough meta-analysis studies, according to the meta-analysis results of Lavazzo and his collagues provided a comprehensive meta-analysis of minimally invasive techniques in myoma surgery in 2016, they concluded that robotic surgery was better than laparoscopic surgery as shown in its less bleeding and blood transfusion need, lower complication rates, and shorter hospital stay in the postoperative period[\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eOn the basis of these findings that robotic surgery may be superior to laparoscopy and will be preferred by surgeons and patients in conservative adenomyosis surgery.\u003c/p\u003e \u003cp\u003eLimitations of this study are the presence of concurrent endometriosis and the fact that endometriosis surgery would be performed at the same time in most of the cases may have an impact on the decision to perform the operation with robotic approach and this can effect pain scores of the patients.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eOverall these results indicate that for patients who desire to preserve their uterus, treatment is the complete removal of the adenomyotic tissue and reducing symptoms but surgical outcomes are not decisive.\u003c/p\u003e \u003cp\u003eFor the patient's comfort, minimal invasive surgery may be preferred. These results highlights the hypothesis, which was that one of the minimally invasive techniques, robotic surgery, can be used in the treatment of adenomyosis, and this may be preferred by surgeons since robotic surgery allows for greater visualization and range of movement when compared to laparoscopy. The superiority of laparoscopy to robotic surgery in perioperative result has not yet been shown clearly in studies. For this reason there has not yet been any proven technique for uterus sparing surgery in the treatment of adenomyosis. Future investigations are necessary to validate the kinds of conclusions that can be drawn from this study. Since the complete removal of adenomyotic tissue is only possible with hysterectomy, we do not have enough information about how much adenomyotic tissue remains in the uterine-sparing surgery group and how much recurrence will occur in the future.\u003c/p\u003e"},{"header":"Statements And Declarations","content":"\u003cp\u003eThe authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eAcknowledgments\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eAll authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [Taner Usta], [Salih Yilmaz]. The first draft of the manuscript was written by [Gizem Nil Ceylan] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n \u003cli\u003eJ. Donnez, O. Donnez, ve M.-M. Dolmans, \u0026ldquo;Introduction\u0026rdquo;, \u003cem\u003eFertil. Steril.\u003c/em\u003e, c. 109, sy 3, ss. 369-370, Mar. 2018, doi: 10.1016/j.fertnstert.2018.01.035.\u003c/li\u003e\n \u003cli\u003eJ. Zhai, S. Vannuccini, F. Petraglia, ve L. C. Giudice, \u0026ldquo;Adenomyosis: Mechanisms and Pathogenesis\u0026rdquo;, \u003cem\u003eSemin. Reprod. Med.\u003c/em\u003e, c. 38, sy 02/03, ss. 129-143, May. 2020, doi: 10.1055/s-0040-1716687.\u003c/li\u003e\n \u003cli\u003eC. Farquhar ve I. Brosens, \u0026ldquo;Medical and surgical management of adenomyosis\u0026rdquo;, \u003cem\u003eBest Pract. Res. Clin. Obstet. Gynaecol.\u003c/em\u003e, c. 20, sy 4, ss. 603-616, Ağu. 2006, doi: 10.1016/j.bpobgyn.2006.01.012.\u003c/li\u003e\n \u003cli\u003eS. Vannuccini ve F. Petraglia, \u0026ldquo;Recent advances in understanding and managing adenomyosis\u0026rdquo;, \u003cem\u003eF1000Research\u003c/em\u003e, c. 8, s. F1000 Faculty Rev-283, 2019, doi: 10.12688/f1000research.17242.1.\u003c/li\u003e\n \u003cli\u003eL. L. Hyams, \u0026ldquo;Adenomyosis; its conservative surgical treatment (hysteroplasty) in young women\u0026rdquo;, \u003cem\u003eN. Y. State J. Med.\u003c/em\u003e, c. 52, sy 22, ss. 2778-2784, Kas. 1952.\u003c/li\u003e\n \u003cli\u003eA. Sun, M. Luo, W. Wang, R. Chen, ve J. Lang, \u0026ldquo;Characteristics and efficacy of modified adenomyomectomy in the treatment of uterine adenomyoma\u0026rdquo;, \u003cem\u003eChin. Med. J. (Engl.)\u003c/em\u003e, c. 124, sy 9, ss. 1322-1326, May. 2011.\u003c/li\u003e\n \u003cli\u003eA. Fujishita, H. Masuzaki, K. N. Khan, M. Kitajima, ve T. Ishimaru, \u0026ldquo;Modified Reduction Surgery for Adenomyosis\u0026rdquo;, \u003cem\u003eGynecol. Obstet. Invest.\u003c/em\u003e, c. 57, sy 3, ss. 132-138, 2004, doi: 10.1159/000075830.\u003c/li\u003e\n \u003cli\u003eM. Nishida, K. Takano, Y. Arai, H. Ozone, ve R. Ichikawa, \u0026ldquo;Conservative surgical management for diffuse uterine adenomyosis\u0026rdquo;, \u003cem\u003eFertil. Steril.\u003c/em\u003e, c. 94, sy 2, ss. 715-719, Tem. 2010, doi: 10.1016/j.fertnstert.2009.03.046.\u003c/li\u003e\n \u003cli\u003eH. Osada, S. Silber, T. Kakinuma, M. Nagaishi, K. Kato, ve O. Kato, \u0026ldquo;Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis\u0026rdquo;, \u003cem\u003eReprod. Biomed. Online\u003c/em\u003e, c. 22, sy 1, ss. 94-99, Oca. 2011, doi: 10.1016/j.rbmo.2010.09.014.\u003c/li\u003e\n \u003cli\u003eG. F. Grimbizis, T. Mikos, ve B. Tarlatzis, \u0026ldquo;Uterus-sparing operative treatment for adenomyosis\u0026rdquo;, \u003cem\u003eFertil. Steril.\u003c/em\u003e, c. 101, sy 2, ss. 472-487.e8, Şub. 2014, doi: 10.1016/j.fertnstert.2013.10.025.\u003c/li\u003e\n \u003cli\u003eC. Benlice \u003cem\u003evd.\u003c/em\u003e, \u0026ldquo;Robotic Surgery for Deep Pelvic Endometriosis With Multidisciplinary Approach: Shaving, Wedge Resection, and Segmental Resection\u0026rdquo;, \u003cem\u003eDis. Colon Rectum\u003c/em\u003e, c. 65, sy 8, ss. e816-e816, Ağu. 2022, doi: 10.1097/DCR.0000000000002353.\u003c/li\u003e\n \u003cli\u003eT. Usta, T. Karacan, A. Kale, S. Mutlu, ve T. Tıryakı, \u0026ldquo;Robot-assisted laparoscopic pectouteropexy: an alternative uterus-sparing technique for pelvic organ prolapse surgery\u0026rdquo;, \u003cem\u003eInt. Urogynecology J.\u003c/em\u003e, c. 28, sy 11, ss. 1751-1753, Kas. 2017, doi: 10.1007/s00192-017-3326-3.\u003c/li\u003e\n \u003cli\u003eC. Jin \u003cem\u003evd.\u003c/em\u003e, \u0026ldquo;Laparoscopic versus open myomectomy--a meta-analysis of randomized controlled trials\u0026rdquo;, \u003cem\u003eEur. J. Obstet. Gynecol. Reprod. Biol.\u003c/em\u003e, c. 145, sy 1, ss. 14-21, Tem. 2009, doi: 10.1016/j.ejogrb.2009.03.009.\u003c/li\u003e\n \u003cli\u003eJ. Y. Kwack, K. S. Im, ve Y.-S. Kwon, \u0026ldquo;Conservative surgery of uterine adenomyosis via laparoscopic versus laparotomic approach in a single institution: Approaching method for adenomyomectomy\u0026rdquo;, \u003cem\u003eJ. Obstet. Gynaecol. Res.\u003c/em\u003e, c. 44, sy 7, ss. 1268-1273, Tem. 2018, doi: 10.1111/jog.13658.\u003c/li\u003e\n \u003cli\u003eL. Zhu, S. Chen, X. Che, P. Xu, X. Huang, ve X. Zhang, \u0026ldquo;Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution\u0026rdquo;, \u003cem\u003eJ. Pain Res.\u003c/em\u003e, c. Volume 12, ss. 1917-1924, Haz. 2019, doi: 10.2147/JPR.S205561.\u003c/li\u003e\n \u003cli\u003eG. Gitas, L. Hanker, A. Rody, J. Ackermann, ve I. Alkatout, \u0026ldquo;Robotic surgery in gynecology: is the future already here?\u0026rdquo;, \u003cem\u003eMinim. Invasive Ther. Allied Technol.\u003c/em\u003e, ss. 1-10, Oca. 2022, doi: 10.1080/13645706.2021.2010763.\u003c/li\u003e\n \u003cli\u003eG. O. Chong, Y. H. Lee, D. G. Hong, Y. L. Cho, ve Y. S. Lee, \u0026ldquo;Long-Term Efficacy of Laparoscopic or Robotic Adenomyomectomy with or without Medical Treatment for Severely Symptomatic Adenomyosis\u0026rdquo;, \u003cem\u003eGynecol. Obstet. Invest.\u003c/em\u003e, c. 81, sy 4, ss. 346-352, 2016, doi: 10.1159/000441783.\u003c/li\u003e\n \u003cli\u003eY. J. Chung, S. Y. Kang, M. R. Choi, H. H. Cho, J. H. Kim, ve M. R. Kim, \u0026ldquo;Robot-Assisted Laparoscopic Adenomyomectomy for Patients Who Want to Preserve Fertility\u0026rdquo;, \u003cem\u003eYonsei Med. J.\u003c/em\u003e, c. 57, sy 6, ss. 1531-1534, Kas. 2016, doi: 10.3349/ymj.2016.57.6.1531.\u003c/li\u003e\n \u003cli\u003eS. E. Barton ve A. R. Gargiulo, \u0026ldquo;Robot-assisted laparoscopic myomectomy and adenomyomectomy with a flexible CO2 laser device\u0026rdquo;, \u003cem\u003eJ. Robot. Surg.\u003c/em\u003e, c. 7, sy 2, ss. 157-162, Haz. 2013, doi: 10.1007/s11701-012-0360-5.\u003c/li\u003e\n \u003cli\u003eJ. Ma \u003cem\u003evd.\u003c/em\u003e, \u0026ldquo;Robot-Assisted Laparoscopic Adenomyomectomy: Successful Treatment of Adenomyosis Patients Who Wish Uterus-Sparing Treatment\u0026rdquo;, \u003cem\u003eJ. Minim. Invasive Gynecol.\u003c/em\u003e, c. 22, sy 6, s. S70, Kas. 2015, doi: 10.1016/j.jmig.2015.08.188.\u003c/li\u003e\n \u003cli\u003eG. O. Chong, Y. H. Lee, D. G. Hong, Y. L. Cho, ve Y. S. Lee, \u0026ldquo;Long-Term Efficacy of Laparoscopic or Robotic Adenomyomectomy with or without Medical Treatment for Severely Symptomatic Adenomyosis\u0026rdquo;, \u003cem\u003eGynecol. Obstet. Invest.\u003c/em\u003e, c. 81, sy 4, ss. 346-352, 2016, doi: 10.1159/000441783.\u003c/li\u003e\n \u003cli\u003eY.-J. Chung, S.-Y. Kang, M.-R. Choi, H.-H. Cho, J.-H. Kim, ve M.-R. Kim, \u0026ldquo;Robot-Assisted Laparoscopic Adenomyomectomy for Patients Who Want to Preserve Fertility\u0026rdquo;, \u003cem\u003eYonsei Med. J.\u003c/em\u003e, c. 57, sy 6, s. 1531, 2016, doi: 10.3349/ymj.2016.57.6.1531.\u003c/li\u003e\n \u003cli\u003eJ. I. Shim \u003cem\u003evd.\u003c/em\u003e, \u0026ldquo;A comparison of surgical outcomes between robot and laparoscopy-assisted adenomyomectomy\u0026rdquo;, \u003cem\u003eMedicine (Baltimore)\u003c/em\u003e, c. 98, sy 18, s. e15466, May. 2019, doi: 10.1097/MD.0000000000015466.\u003c/li\u003e\n \u003cli\u003eA. Hijazi \u003cem\u003evd.\u003c/em\u003e, \u0026ldquo;Efficient myometrial defect closure in a layer by layer fashion after robot-assisted laparoscopic adenomyomectomy: a novel technique\u0026rdquo;, \u003cem\u003eObstet. Gynecol. Sci.\u003c/em\u003e, c. 64, sy 3, ss. 332-335, May. 2021, doi: 10.5468/ogs.21025.\u003c/li\u003e\n \u003cli\u003eC. Iavazzo, I. Mamais, ve I. D. Gkegkes, \u0026ldquo;Robotic assisted vs laparoscopic and/or open myomectomy: systematic review and meta-analysis of the clinical evidence\u0026rdquo;, \u003cem\u003eArch. Gynecol. Obstet.\u003c/em\u003e, c. 294, sy 1, ss. 5-17, Tem. 2016, doi: 10.1007/s00404-016-4061-6.\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Adenomyomectomy, adenomyosis, uterus-sparing surgery, robotic surgery, fertility","lastPublishedDoi":"10.21203/rs.3.rs-2322563/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-2322563/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eAdenomyosis is a benign uterine disorder where endometrial gland and stromal tissue are abnormally located within the myometrium. The common symptoms of adenomyosis are abnormal uterine bleeding (menorrhagia), dysmenorrhea, dyspareunia and infertility.\u003c/p\u003e\n\u003cp\u003eThe gold-standard method for\u0026nbsp;treating adenomyosis is hysterectomy. For patients who desire to preserve their uterus, an alternative therapy would be adenomyomectomy which is sparing uterus. Such a procedure may be performed with open surgery or minimally invasive surgery.\u003c/p\u003e\n\u003cp\u003eIt is obvious that minimal invasive surgery would be better for the patient’s health. However, there is inadequate evidence to decidedly say which invasive surgery which invasive surgery would be best for the patient. We suggest that one of the newest techniques, robotic surgery is to be preferred an alternative approach for gynecological operations as well as would be an option for uterine surgery. \u0026nbsp;This technique would allow for 3-D visualization and multijoint endowrist movement, which compared to laparoscopy, yields various advantages for surgeons.\u003c/p\u003e\n\u003cp\u003eWe therefore recruit seven participants diagnosed with symptomatic adenomyosis who admitted to Endometriosis and Chronic Pelvic Pain Center of Acibadem Altunizade Hospital between March 2019and January 2021 requested to preserve fertility. They all underwent robotic adenomyomectomy. The parameters evaluated herein will be, whether the pain and bleeding scores changed during the postoperative period, amount of blood loss during the operation and the associated decrease in Hg levels. Robotic adenomyomectomy is one of the uterus-sparing adenomyosis surgery methods and is safely applied in selected patients.\u003c/p\u003e","manuscriptTitle":"Robot-assisted Laparoscopic Adenomyomectomy","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2022-12-01 16:20:00","doi":"10.21203/rs.3.rs-2322563/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"4fb74e9e-911c-4dae-a11e-5e3584a65805","owner":[],"postedDate":"December 1st, 2022","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2022-12-04T22:59:11+00:00","versionOfRecord":[],"versionCreatedAt":"2022-12-01 16:20:00","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-2322563","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-2322563","identity":"rs-2322563","version":["v1"]},"buildId":"WvIrzKhiLBfengagbw6Ux","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}